IBDEI3IB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=RELATIONAL PROBLEMS^23^99
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^25^99
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=SEXUAL DYSFUNCTION^26^99
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=SLEEP DISORDERS^27^99
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=SUBSTANCE ABUSE-ALCOHOL^30^99
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=SUBSTANCE ABUSE-AMPHETAMINE^31^99
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=SUBSTANCE ABUSE-CANNABIS^32^99
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^34^99
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=SUBSTANCE ABUSE-OPIOID^36^99
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^37^99
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^38^99
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=SUBSTANCE ABUSE-TOBACCO^39^99
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=SUBSTANCE ABUSE-COCAINE^33^99
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^40^99
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=SUBSTANCE ABUSE-INHALANT^35^99
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=INTELLECTUAL DISABILITIES^15^99
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=RESEARCH^24^99
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=SOMATOFORM DISORDERS^29^99
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=ORTHOTIC DEVICES^3^100
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=THERAPY EVALUATIONS^5^100
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=HOME THERAPY SERVICES^1^100
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=KT HOME HEALTH SERVICES^2^100
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=SPEECH/LANG HOME HEALTH SERVICE^4^100
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=AMPUTATION STATUS^1^101
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=BRAIN DISORDERS^2^101
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=CARDIOPULMONARY^4^101
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=COMPLICATIONS DUE TO^5^101
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^11^101
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=Z CODES^16^101
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=BRAIN INJURY - TRAUMATIC^3^101
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=FEMUR/THIGH/KNEE FRACTURE^6^101
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=FOOT/TOE/ANKLE FRANCTURE^7^101
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=HAND/FINGER FRACTURE^8^101
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=HIP/PELVIS FRACTURE^9^101
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=HUMERUS/SHOULDER FRACTURE^10^101
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=TIBIA/FIBULA FRACTURE^14^101
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=SPINE FRACTURE^13^101
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=WRIST/FOREARM FRACTURE^15^101
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=OTHER FRACTURE^12^101
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=SPECIAL SERVICES^7^102
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=TREATMENT^8^102
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=MISCELLANEOUS^5^102
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=IMMUNIZATIONS^3^102
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=CHEMO ADMINISTRATION^1^102
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=CHEMO DRUGS^2^102
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=OTHER DRUGS^6^102
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=MGMT L/T ANTICOAG TX^4^102
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=NEW PATIENT^2^103
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=ESTABLISHED PATIENT^1^103
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=CONSULTATIONS^3^103
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=POST OP^4^103
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=ANEMIA^1^104
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=BREAST & GYN NEOPLASMS^2^104
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=COAGULATION DISORDERS^3^104
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=COUNSELING & SCREENING^4^104
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=GENITOURINARY NEOPLASMS^5^104
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=GI CANCER^6^104
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=HEAD/NECK/LUNG CANCER^7^104
